Source link : https://www.newshealth.biz/health-news/extended-zerlasiran-data-show-sustained-lpa-reduction/
Treatment with zerlasiran produced sustained reductions in lipoprotein(a) [Lp(a)] concentrations out to 1 year in adults with elevated Lp(a), extended data from the APOLLO phase 1 trial showed. “Zerlasiran produces a prolonged reduction in Lp(a). This study was designed to determine how long it would work and what’s the right dose,” Steven E. Nissen, MD, […]
Author : News Health
Publish date : 2024-04-12 05:26:01
Copyright for syndicated content belongs to the linked Source.